Respiratory Medicine
Volume 104, Issue 4 , Pages 518-524, April 2010

Temazepam 10mg does not affect breathing and gas exchange in patients with severe normocapnic COPD

  • Gerben Stege

      Affiliations

    • Department of Pulmonology, Rijnstate Hospital, Arnhem, The Netherlands
    • Corresponding Author InformationCorresponding author. Department of Pulmonology, Rijnstate Hospital, P.O. Box 9555, 6800 TA, Arnhem, The Netherlands. Tel.: +31 (0) 26 3786226; fax: +31 (0) 26 3786124.
  • ,
  • Yvonne F. Heijdra

      Affiliations

    • Department of Pulmonology, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands
  • ,
  • Frank J.J. van den Elshout

      Affiliations

    • Department of Pulmonology, Rijnstate Hospital, Arnhem, The Netherlands
  • ,
  • Marjo J.T. van de Ven

      Affiliations

    • Department of Pulmonology, Rijnstate Hospital, Arnhem, The Netherlands
  • ,
  • Peter J. de Bruijn

      Affiliations

    • Department of Pulmonology, Rijnstate Hospital, Arnhem, The Netherlands
  • ,
  • Adriaan A. van Sorge

      Affiliations

    • Department of Clinical Pharmacy & Pharmacology, Rijnstate Hospital, Arnhem, the Netherlands
  • ,
  • P.N. Richard Dekhuijzen

      Affiliations

    • Department of Pulmonology, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands
  • ,
  • Petra J.E. Vos

      Affiliations

    • Department of Pulmonology, Rijnstate Hospital, Arnhem, The Netherlands

Received 22 December 2008; accepted 27 October 2009. published online 13 November 2009.

Summary 

Background

Benzodiazepines can improve sleep quality, but are also thought to cause respiratory depression in patients with chronic obstructive pulmonary disease (COPD). The aims of this study were to assess the effects of temazepam on indices of circadian respiratory function, dyspnea, sleep quality, and sleepiness in patients with severe COPD and insomnia.

Methods

In a double-blind, randomized, placebo-controlled, cross-over study in 14 stable patients with COPD (mean FEV1 0.99±0.3L) with insomnia, polysomnography with continuous transcutaneous capnography and oximetry, arterial gas sampling, hypercapnic ventilatory response, multiple sleep latency test, Epworth Sleepiness Scale, dyspnea and sleep visual analogue scales (VAS) were performed at baseline, after one week of temazepam 10mg at bedtime and after one week of placebo.

Results

Temazepam did not cause statistically significant changes in mean transcutaneous carbon dioxide tension during sleep compared to placebo (5.9±1.0kPa vs. 6.3±1.4kPa, p-value 0.27), nor in mean oxygen saturation (92±3% vs. 92±2%, p-value 0.31), nor in any of the other investigated variables, except for the total sleep time and sleep latency VAS, which improved with temazepam.

Conclusions

One week usage of temazepam 10mg does not influence circadian respiratory function, dyspnea, and sleepiness in patients with stable, severe, normocapnic COPD and insomnia and it improves total sleep time and subjective sleep latency. However, this is a preliminary explorative study for assessing the feasibility to perform a larger study on this topic. The clinical implications of this study are very limited.

Keywords: Benzodiazepines, Chronic Obstructive Pulmonary Disease, Gas exchange, Insomnia, Sleep, Temazepam

Abbreviation list: ABG, arterial blood gas, AHI, apnea–hypopnea-index, COPD, chronic obstructive pulmonary disease, DI, desaturation index, HCVR, hypercapnic ventilatory response, HR, heart rate, PaCO2, arterial partial pressure of carbon dioxide, PaO2, arterial partial pressure of oxygen, PetCO2, end-tidal partial pressure of carbon dioxide, PtcCO2, transcutaneous partial pressure of carbon dioxide, PSG, polysomnography, REM, rapid eye movements, SaO2, arterial saturation of oxygen, SpO2, functional saturation of oxygen, TST, total sleep time, VAS, visual analogue scale

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This study was registered at www.ClinicalTrials.gov as ‘Effects of temazepam in patients with chronic pulmonary obstructive disease’ (ID number NCT00245661).

PII: S0954-6111(09)00357-6

doi:10.1016/j.rmed.2009.10.022

Respiratory Medicine
Volume 104, Issue 4 , Pages 518-524, April 2010